We provide evidence in CRC that Cla exerts antiproliferative activity and enhances the antitumor effects of chemotherapeutic drugs, through a complex modulation of autophagy brought about by an hERG1–dependent regulation of the PI3K/Akt pathway and p53. This evidence concerns the gene TP53 and colorectal carcinoma.